Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1979 2
1983 1
1984 3
1985 1
1987 1
1988 1
1990 1
1991 6
1993 1
1994 2
1995 1
1996 2
1997 4
1998 3
1999 3
2000 3
2001 3
2002 3
2003 5
2004 2
2005 5
2006 7
2007 6
2008 6
2009 8
2010 8
2011 8
2012 5
2013 7
2014 16
2015 14
2016 14
2017 16
2018 19
2019 21
2020 23
2021 25
2022 26
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean high dose vitamin e cancer (294 results)?
Targeting cancer vulnerabilities with high-dose vitamin C.
Ngo B, Van Riper JM, Cantley LC, Yun J. Ngo B, et al. Nat Rev Cancer. 2019 May;19(5):271-282. doi: 10.1038/s41568-019-0135-7. Nat Rev Cancer. 2019. PMID: 30967651 Free PMC article. Review.
Over the past century, the notion that vitamin C can be used to treat cancer has generated much controversy. However, new knowledge regarding the pharmacokinetic properties of vitamin C and recent high-profile preclinical studies have revived in …
Over the past century, the notion that vitamin C can be used to treat cancer has generated much controversy. However, n …
High-dose vitamin C enhances cancer immunotherapy.
Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, Abrignani S, D'Incalci M, Zucchetti M, Di Nicolantonio F, Bardelli A. Magrì A, et al. Sci Transl Med. 2020 Feb 26;12(532):eaay8707. doi: 10.1126/scitranslmed.aay8707. Sci Transl Med. 2020. PMID: 32102933 Free article.
Vitamin C (VitC) is known to directly impair cancer cell growth in preclinical models, but there is little clinical evidence on its antitumoral efficacy. ...Here, we show that a fully competent immune system is required to maximize the antiproliferative effec …
Vitamin C (VitC) is known to directly impair cancer cell growth in preclinical models, but there is little clinical evi …
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. Böttger F, et al. J Exp Clin Cancer Res. 2021 Oct 30;40(1):343. doi: 10.1186/s13046-021-02134-y. J Exp Clin Cancer Res. 2021. PMID: 34717701 Free PMC article. Review.
Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). ...A special focus is put on global molecular profiling studies in this respect. In …
Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intrave …
High-Dose Vitamin C in Advanced-Stage Cancer Patients.
Zasowska-Nowak A, Nowak PJ, Ciałkowska-Rysz A. Zasowska-Nowak A, et al. Nutrients. 2021 Feb 26;13(3):735. doi: 10.3390/nu13030735. Nutrients. 2021. PMID: 33652579 Free PMC article. Review.
High-dose intravenously administered vitamin C (IVC) is widely used in cancer patients by complementary and alternative medicine practitioners. ...We also have not found the rationale for the use of IVC to increase the effectiveness of chemother …
High-dose intravenously administered vitamin C (IVC) is widely used in cancer patients by complementary a …
High-Dose Vitamin C for Cancer Therapy.
Mussa A, Mohd Idris RA, Ahmed N, Ahmad S, Murtadha AH, Tengku Din TADAA, Yean CY, Wan Abdul Rahman WF, Mat Lazim N, Uskoković V, Hajissa K, Mokhtar NF, Mohamud R, Hassan R. Mussa A, et al. Pharmaceuticals (Basel). 2022 Jun 3;15(6):711. doi: 10.3390/ph15060711. Pharmaceuticals (Basel). 2022. PMID: 35745630 Free PMC article. Review.
In recent years, the idea that Vitamin C (Vit-C) could be utilized as a form of anti-cancer therapy has generated many contradictory arguments. ...Moreover, upcoming studies should focus on how to define the most suitable cancer patient populations for …
In recent years, the idea that Vitamin C (Vit-C) could be utilized as a form of anti-cancer therapy has generated many …
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients.
Giansanti M, Karimi T, Faraoni I, Graziani G. Giansanti M, et al. Cancers (Basel). 2021 Mar 20;13(6):1428. doi: 10.3390/cancers13061428. Cancers (Basel). 2021. PMID: 33804775 Free PMC article. Review.
High-dose vitamin C has been proposed as a potential therapeutic approach for patients with advanced tumors who failed previous treatment with chemotherapy. ...Moreover, vitamin C entry into cells is tightly regulated by SVCT and GLUT tra …
High-dose vitamin C has been proposed as a potential therapeutic approach for patients with advanced tumors who …
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX Bevacizumab versus FOLFOX Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).
Wang F, He MM, Xiao J, Zhang YQ, Yuan XL, Fang WJ, Zhang Y, Wang W, Hu XH, Ma ZG, Yao YC, Zhuang ZX, Zhou FX, Ying JE, Yuan Y, Zou QF, Guo ZQ, Wu XY, Jin Y, Mai ZJ, Wang ZQ, Qiu H, Guo Y, Shi SM, Chen SZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. Wang F, et al. Clin Cancer Res. 2022 Oct 3;28(19):4232-4239. doi: 10.1158/1078-0432.CCR-22-0655. Clin Cancer Res. 2022. PMID: 35929990 Free PMC article. Clinical Trial.
PURPOSE: To compare the efficacy and safety of high-dose vitamin C plus FOLFOX bevacizumab versus FOLFOX bevacizumab as first-line treatment in patients with metastatic colorectal cancer (mCRC). ...In prespecified subgroup analyses, patients wit …
PURPOSE: To compare the efficacy and safety of high-dose vitamin C plus FOLFOX bevacizumab versus FOLFOX bevaciz …
The NF-kappaB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer.
Mussa A, Afolabi HA, Syed NH, Talib M, Murtadha AH, Hajissa K, Mokhtar NF, Mohamud R, Hassan R. Mussa A, et al. Biomedicines. 2023 Mar 30;11(4):1060. doi: 10.3390/biomedicines11041060. Biomedicines. 2023. PMID: 37189677 Free PMC article. Review.
Moreover, the crosstalk between NF-kappaB and other transcription factors is well documented. It is reported that vitamin C plays a key role in preventing and treating a number of pathological conditions, including cancer, when administered at remarkably high …
Moreover, the crosstalk between NF-kappaB and other transcription factors is well documented. It is reported that vitamin C pl …
[Does high-dose intravenous vitamin C has anti-cancer activity ?].
Courtes MG, Baudoux N, Astaras C, Fernandez E. Courtes MG, et al. Rev Med Suisse. 2022 May 18;18(782):1002-1006. doi: 10.53738/REVMED.2022.18.782.1002. Rev Med Suisse. 2022. PMID: 35583280 Clinical Trial. French.
High-dose intravenously (i.v) vitamin C in cancer patients is controversial. ...In cancer patients, high-dose i.v vitamin C in monotherapy does not show any anti-cancer activity. ...
High-dose intravenously (i.v) vitamin C in cancer patients is controversial. ...In cancer patients …
Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms.
Su X, Shen Z, Yang Q, Sui F, Pu J, Ma J, Ma S, Yao D, Ji M, Hou P. Su X, et al. Theranostics. 2019 Jun 9;9(15):4461-4473. doi: 10.7150/thno.35219. eCollection 2019. Theranostics. 2019. PMID: 31285773 Free PMC article.
Background: Vitamin C has been demonstrated to kill BRAF mutant colorectal cancer cells selectively. ...We demonstrated that the elevated level of Vitamin C in the plasma following a high dose of intraperitoneal injection dramatica …
Background: Vitamin C has been demonstrated to kill BRAF mutant colorectal cancer cells selectively. ...We demonstrated …
280 results